NCT02881827

Brief Summary

The purpose of this study is to obtain experimental data on the possible changes that saliva may suffer when brought to low-level laser therapy protocols for analgesia in the masseter muscle, because this be on the Parotid salivary gland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 29, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

August 29, 2016

Status Verified

August 1, 2016

Enrollment Period

2.6 years

First QC Date

August 9, 2016

Last Update Submit

August 26, 2016

Conditions

Keywords

SalivaLow-level laser therapyMasseter muscleSalivary glands

Outcome Measures

Primary Outcomes (1)

  • Increased salivary flow

    Expect positive results of this research on the increased salivary flow , improved saliva buffer capacity as well as increased salivary pH enabling a better quality of life for patients.

    24 months

Secondary Outcomes (1)

  • Improvement of the salivary pH

    24 months

Other Outcomes (1)

  • Increase in saliva buffer capacity

    24 months

Study Arms (4)

Infrared Laser

ACTIVE COMPARATOR

Using a laser in the infrared wave spectrum (780 nm)

Radiation: Low level laser therapy

Red Laser

ACTIVE COMPARATOR

Using laser red wave spectrum (662 nm)

Radiation: Low level laser therapy

Placebo

PLACEBO COMPARATOR

Simulation of treatment with the device switched off

Other: Placebo

Control

ACTIVE COMPARATOR

A scientific control group allows the experimental study of a variable at a time, and is a vital part of the scientific method. In a controlled experiment, two identical experiments are conducted. In one, the treatment - tested factor - is applied. In another - control - the tested factor is not applied For example, when testing a drug, it is important to carefully check the suspected drug effects are produced by the drug. Doctors can it with a double-blind study in a clinical trial: two ( statistically ) identical groups of patients are compared, one gets the drug and the other receives a placebo. Neither subjects nor investigators know which group receives the actual drug , which serves to prevent bias and isolating effects of such drugs.

Other: Control

Interventions

Supported by the physical phenomenon of stimulated emission postulated by Albert Einstein in 1916 the laser (light amplification by Stimulated Emission of Radiation) is a device consisting of solid source materials, liquid or gas that produces beams of light when excited by a source of energy. This bright feature is a particular type of electromagnetic radiation, which differs from that emitted by conventional incandescent sources. These are the effects attributable to LLLT analgesic, anti-inflammatory and biostimulates and has been widely used due to low power densities and wavelengths with a penetration capacity in tissues without the generation of photothermal effects, which makes its feasible use multiple applications in Health area.

Infrared LaserRed Laser
PlaceboOTHER

Simulation of treatment with the device switched off

Placebo
ControlOTHER

A scientific control group allows the experimental study of a variable at a time, and is a vital part of the scientific method. In a controlled experiment, two identical experiments are conducted. In one, the treatment - tested factor - is applied. In another - control - the tested factor is not applied. For example, when testing a drug, it is important to carefully check the suspected drug effects are produced by the drug. Doctors can it with a double-blind study in a clinical trial: two (statistically) identical groups of patients are compared, one gets the drug and the other receives a placebo. Neither subjects nor investigators know which group receives the actual drug, which serves to prevent bias and isolating effects of such drugs.

Control

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Have all dental organs
  • Male volunteers
  • Age between 18 and 30 years
  • Body mass index between 18.5 and 25 (normal) .

You may not qualify if:

  • Presence of problems that compromise the physiological activity of the masticatory system
  • Neurological disorders
  • Cerebral Palsy
  • parafunctions :
  • Sucking fingers
  • Nail biting
  • Nibble objects
  • Bruxism
  • Mouth breathing .
  • Use of medication :
  • Antihistamines
  • Benzodiazepines
  • Depressants of the central nervous system.
  • Temporomandibular dysfunction:
  • Clenching of the teeth
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leandro Júnio Masulo

São José dos Campos, São Paulo, 55, Brazil

Location

Related Links

MeSH Terms

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2016

First Posted

August 29, 2016

Study Start

January 1, 2014

Primary Completion

August 1, 2016

Study Completion

September 1, 2018

Last Updated

August 29, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

Locations